Clinical Trial Update: Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a thiotepa, cyclophosphamide, clarithromycin, and cytarabine combination in adults with Burkitt lymphoma, lymphoblastic lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma
• Lymphoblastic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• THIOTEPA (THIOTEPA)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University | Conditions: Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult | Phase 1 | Status: RECRUITING